INTRODUCTION
The transport of the essential micronutrient cobalamin (Cbl, vitamin B 12 ) from food to cells relies on three successive proteins in mammals, haptocorrin (HC), gastric intrinsic factor (IF) and transcobalamin (TC) [1] [2] [3] . Cbl is required by cells as the basis for two enzyme cofactors, methyl-Cbl for methionine synthase and 5'-deoxyadenosyl-Cbl (Ado-Cbl) for methyl-malonyl-CoA mutase [4] . Upon initial uptake of Cbl from food, Cbl becomes bound in the stomach to salivary HC. After proteolysis of HC in the duodenum, Cbl is passed on to IF. Mucosal cells in the ileum absorb the IF-Cbl complex via endocytosis mediated by a specific receptor. In the enterocyte, the IF-Cbl complex is degraded and Cbl is transferred to TC which delivers Cbl to cells via the blood [5] . Only the fraction of Cbl bound to TC is taken up via endocytosis by a specific receptor on most cell types. HC that is also present in plasma cannot facilitate cellular uptake of Cbl with the exception of hepatocytes. TC-Cbl is degraded in lysozomes to release Cbl for further conversion into the important cofactors. Cbl-deficiency as a result of impaired intestinal absorption is more common among the elderly population and may lead to disorders including hematologic abnormalities and defects in the nervous system and metabolism [6] . Table 1 summarizes some properties of the human Cbl-transporters. Investigation of their gene structure suggested that the three proteins have a common evolutionary origin and that TC has diverged first from the ancestral gene [7] . The homologous Cbl-transporters show about 25% overall sequence identity but several shorter stretches possess considerably higher similarity. Glycosylation is observed for IF and to an even higher extent for HC, but not for TC [2] . The proteins have extraordinary affinity for the vitamin, with similar K d values < 1 pM [8] . However, they show differences in their specificity for Cbl analogues, which are as well produced by microorganisms [9] .
Very recently, the structures of human and bovine TC in complex with Cbl have been solved by X-ray crystallography [10] . These allowed the detailed description of the Cbl-binding mode and represent the prototype for the family of mammalian Cbl-transporters since no structures have been reported yet for IF or HC. Their structure determination by X-ray crystallography is likely to remain challenging due to difficulties with crystallization of these highly glycosylated proteins. Detailed structural information for IF and HC is of importance for understanding their way of function in greater detail, especially the interactions with the ligand Cbl, the role of glycosylation and the recognition by specific cell surface receptors.
In particular, knowledge of the Cbl-binding mode for all three proteins is essential to rationalize the observed diversity in ligand specificity. IF shows the highest specificity for Cbl and is suggested to select in the first place genuine Cbl among Cbl analogues in the diet, while HC as the least specific binder may remove other Cbl analogues from the circulation that can harmfully compete for the binding site of Cbl in methionine synthase and methyl-malonyl-CoA mutase [9] . The precise physiological role of HC within the complex process of Cbl internalization is not yet well understood. Furthermore, the structural basis for ligand specificity is of interest in view of the design of Cbl-based bioconjugates. Such bioconjugates show potential as cytotoxic drugs or imaging agents in cancer treatment [11] or may function as Cbl-
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competitors to selectively block cell growth in the treatment of AIDS-related lymphoma [12] or cancer [13] . These applications are based on the observation that proliferating cells express more surface receptors for holo-TC, and thus take up proportionally more Cbl, than cells in the stationary phase [11, 14] .
In this study we analyze all three Cbl-transporters regarding structural determinants of ligand specificity. For this purpose, we produced comparative models of Cbl-complexed human IF and HC guided by our recently determined X-ray structures of human and bovine TC. The models are validated with the help of available experimental data for a variety of structural features and are compared to the human TC structure.
METHODS

Modelling
The comparative modelling of IF and HC is based on the structures of human and bovine TC determined by X-ray crystallography (PDB accession codes 2BB5 and 2BB6, respectively [10] ) and on a multiple sequence alignment of IF and HC with these two TC forms shown in Figure 1 . This alignment was extracted from a larger multiple sequence alignment to increase its accuracy, employing the following 16 mammalian Cbl-transporting proteins: TC from man (SwissProt entry P20062), chimpanzee (XP_525562), orangutan (Q5REL7), dog (XP_543481), rat (Q9R0D6), mouse (O88968) and cow (Q9XSC9); IF from man (P27352), dog (Q5XWD5), rat (P17267), mouse (P52787) and cow (XP_873322); HC from man (P20061), dog (XP_855361), cow (XP_873306) and hog (P17630). The alignment was performed with CLUSTALW v.1.82 [15] with the Gonnet 250 scoring matrix. 10 models were calculated both for IF and HC by MODELLER 8v1 [16] using default parameters. The Cbl ligand of the TC template structures were included as rigid body ("block residue" definition in MODELLER) whereas water molecules were excluded from the templates. Conserved disulfide bridges were automatically used as geometric restraints for IF and HC. The best model was chosen according to MODELLER's lowest objective function criterion. The respective best model was subsequently refined iteratively by geometry idealization with REFMAC5 [17] and model rebuilding with the graphics program O [18] . The energy profile (MODELLER's DOPE score) of the models was compared to those of the experimentally determined TC structures. The model geometry was analysed with MOLPROBITY [19] regarding Ramachandran plot, van der Waals contacts, hydrogen bonds and steric clashes and with PROCHECK [20] regarding amino acid stereochemistry. Cavities in the models accessible to a probe of 1.4 Å radius (corresponding to a water molecule) were found with the program CAVENV [21] and visualized with O. Root mean square (rms) deviations of Cα-atoms in a pair of models were calculated by
Deposition of atomic coordinates
The atomic coordinates have been deposited in the Protein Data Bank (http://www.rcsb.org) with accession number 2CKT for IF and 2CKV for HC.
RESULTS AND DISCUSSION
Description of the IF and HC models and comparison to TC
Comparative models were produced for the human forms of IF and HC on the basis of the sequence alignment with human and bovine TC ( Figure 1 ) and guided by the recently determined crystal structures of human and bovine TC [10] . The overall correctness of the modelling is indicated by the absence of bad overlaps and large holes. The models show compact globular domains, well defined hydrogen-bonds for buried polar residues and secondary structure elements, as well as extended hydrophobic domain cores. Table 2 , including also the two TC forms. The regions of elevated similarity between the Cbl-transporters in the sequence alignment of Figure 1 were mapped on the experimentally determined human TC structure. Regarding the α-domain, these regions coincide with the inner six (evennumbered) helices, i.e. the core of the domain, while similarity is spread over the entire β-domain.
An experimental proof of the presence of a two-domain architecture in human IF has been given previously [24, 25] . Two fragments, about 30 kDa and 20 kDa in size, were obtained from natural proteolysis of recombinant IF (50 kDa) and closely corresponded to the α-and β-domain of TC according to their N-terminal sequencing. Each fragment alone was able to bind Cbl with high affinity and a mixture of both fragments, provided the presence of Cbl, could be assembled into a ternary complex which behaved in a very similar way as uncleaved IF-Cbl regarding Cbl-binding and receptor recognition.
The finding [26] that truncation of 50 amino acids from the C-terminal end of human IF abolished its 5 found between helices α4 and α5 in TC, between α8 and α9 in HC and between strands β1 and β2 in IF. 
Glycosylation sites
All glycosylation sites that were predicted on the basis of the Asn-X-Thr/Ser consensus sequence are found to be solvent-exposed in our comparative models ( Figure 2 ). The IF model shows glycosylation sites exclusively on the β-domain, as was confirmed experimentally [24] . Asn 293 was suggested to be glycosylated due to the inability to identify this particular residue during sequencing. Instead, HC also possesses two potential glycosylation sites on the α-domain which fall on the surface region recently proposed as receptor-recognition site of TC [10] . The presence of carbohydrates on the α-domain of HC,
but not on TC, may therefore explain how cell surface receptors for TC discriminate between the two plasma Cbl-transporters TC and HC. Moreover, assuming that the receptor-recognition site is located on the α-domain alone [26] , the lack of carbohydrates on the α-domain of IF may account for the observation that glycosylation does not effect receptor-binding of IF [28] . Recently, however, the presence of both domains was found to be required for binding of IF to its specific receptor cubilin [25] . the isolated β-domain with higher affinity than to the isolated α-domain [25] .
Ligand specificity of the three Cbl-transporters
An early study [9] demonstrated that the affinity of both IF and TC for 14 different Cbl analogues decreases upon modification of the corrin side chains or the nucleotide moiety. In contrast, HC tolerates major structural differences and even the total lack of the nucleotide moiety. A later study focused on the influence of modifications at the nucleotide moiety on ligand recognition [31] . These assays allowed to file Cbl-binding specificities in the order HC << TC < IF. The likely physiological role thereof implies that the most specific protein IF filters out various Cbl analogues before they pass to the plasma, whereas HC in the blood plasma acts as a scavenger of potentially toxic Cbl-analogues, thus exploiting its lowest level of discrimination among the three transporters.
Attempts to explain the observed differences in specificity have so far been unsuccessful. Earlier, a correlation between His-Co coordination on the upper side of the corrin ring (as is observed for TC) and high ligand selectivity was ruled out by comparative kinetic analysis [8] . The lack of correlation is now corroborated by our finding that the His-Co coordination is present neither in IF nor in HC. Analysis of conservations among the transporters' primary structure, even if supplemented by the detailed knowledge of Cbl interactions with TC [10] , did not suffice to identify crucial residues for ligand specificity. This prompted us to produce and examine comparative models for IF and HC in order to address this issue on the level of tertiary structures.
In the following, our structural analysis of ligand specificity is based on observations from affinity measurements that employ a variety of Cbl analogues [9, 31] . The affinity of a transport protein for a concerning the nucleotide arm, in particular the DMB moiety.
The first three analogues in the Supplementary Table 2 involve the replacement of a neutral amide group with a negatively charged carboxyl group at one of the corrin side chains b, d or e (see Figure 4 and the on-line Multimedia adjuncts). Each of these replacements leads in all three protein models to the loss of H-bond interactions to main chain oxygen atoms (Table 3) . However, the replacement shows little connected to significant loss of affinity nor differences in affinity among the three proteins and, as judged from our models, does not result in steric clash.
The second group of analogues in the Supplementary Table 2 involves modifications at the DMB moiety on the lower side ("α-side") of Cbl. This group can be divided into analogues which preserve the coordination bond between the Co ion and the nitrogen atom N3B of DMB (analogues 6-14 in "base-on" form) and those which do not (analogues 15-19 in "base-off" form). Some analogues were examined in both studies (analogues 7, 10, 12, 16). In the study by Kolhouse and Allen [9] , affinity ratios are systematically lower than those obtained by Stupperich and Nexø [31] . These lower affinities might be due to contamination of protein samples with trace amounts of CN-Cbl or other CN-Cbl analogues, as stated by the authors [9] . Stupperich and Nexø concluded that modifications on the DMB moiety are tolerated by all binding proteins as long as the Co-DMB coordination is left intact [31] . Upon disruption of this coordination bond, both IF and, to a slightly smaller extent, TC show strongly decreased affinity, in contrast to HC which maintains most of its affinity. Generally, the size of the nucleotide's base had only minor effects on the affinity constants. These conclusions are in full agreement with structural
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features of our protein models. Smaller modifications at the DMB can be accommodated by the proteins' environment around the nucleotide base ( Figure 4 and the on-line Multimedia adjuncts). For base-off analogues, the models suggest that in the final holo-form of the transporter, the nucleotide moiety should approach the Co ion in a way similar to a base-on form in order to avoid major steric clashes.
A striking difference among the Cbl-transporters is the ability of HC to bind with high affinity even those analogues that lack the nucleotide moiety, such as cobinamide (Cbi). In all transporter models, the lower side of Cbl which hosts the nucleotide moiety is surrounded by a region built of the β−hairpin motif β3-turn-β4. It resembles an "arm" at one side of the β-domain as "body" ( Figure 4A ). HC shows the unique feature of three large residues in van der Waals contact with the nucleotide. We predict that mutations in HC at one or several positions of the three mentioned residues significantly change the binding of Cbl-analogues. Replacing these large residues with smaller residues, such as serine or threonine as present in TC or IF, is expected to deteriorate the packing of the apolar lower side of Cbi to the hairpin motif. Likewise, mutations to render TC and IF equal to HC at the three residues should produce less selective forms of these two Cbl-transporters. In addition, the results of such a study may answer the question whether or not binding of Cbl-analogues without the nucleotide moiety involves structural rearrangements also outside the interface between the analogue and the protein, for instance, in regions determining the flexibility of the hairpin motif.
Binding of Cbl-bioconjugates to TC
In addition to the Cbl analogues compiled in the Supplementary Table 2 , binding of Cbl bioconjugates has been studied in great detail for TC [12, [32] [33] [34] . The effect that the attachment of a molecule to Cbl had on the interaction with TC was systematically investigated in competitive binding assays using Co ion or the 5'-hydroxyl of the ribose moiety had little effect on binding [12] . These results are rationalized by the three-dimensional structure of human holo-TC [10] , showing that sites of conjugation with minor impact on binding are indeed those which suffer less from steric problems with the surrounding protein, i.e. the β-axial position of Co, the 5'-hydroxyl and the side chain e. These locations can accommodate conjugates without restriction on size if an appropriate spacer moiety is inserted between Cbl and the conjugate [12, 32, 34] .
For the use of Cbl derivatives as therapeutic or diagnostic agents, the correct binding of the derivative to TC is not the only requisite. It is of importance that a complex of TC with a Cbl-derivative shows cellular uptake and intracellular trafficking similar to that of the complex of TC with natural Cbl. McLean et al. investigated the ability of monomeric and dimeric Cbl derivatives to block the growth of leukemia cells [13] . They found that all those bioconjugates with modifications at the side chain e were good inhibitors of cell proliferation in that they act as competitors with natural Cbl for binding to TC and, at the same time, do not allow coenzyme activity. The constraint that Cbl conjugation should not alter too much the binding affinity to the transport protein holds additionally for IF and HC if the resulting derivative is intended for oral administration. Our comparative models suggest that the functional groups of Cbl can accommodate conjugates in a similar way when bound to IF or TC. In the case of HC, however, available space at the corrin side chains appears more restricted.
In conclusion, this study presented the first structural comparison of the three human Cbl-transport The upper diagonal gives sequence identities (relative to the longer sequence in each pair) and, in parenthesis, sequence similarity ("positives" in the substitution matrix of Henikoff and Henikoff [36] ).
The lower diagonal reports rms deviations of Cα-atoms for equivalenced residues in the models superimposed with DALI [22] . The number of these residues is given in parenthesis. TC_hum 
YLHSLKLGYQQCLLGSAFSEDDGDCQGKPSMGQLALYLLALRANCEFVRGH--KGDRLVS 111 TC_bov YLHSLKLSYQQSLLRPASNKDDNDSEAKPSMGQLALYLLALRANCEFIGGR--KGDRLVS 111 HC_hum MIQQIKYNVKSRLSD-------------VSSGELALIILALG-VCRNAEENLIYDYHLTD 97 IF_hum AQKLLTYQLMSSDNND------------LTIGHLGLTIMALTSSCRDPG----------D
